Drugs / Qizhiweitong granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02460601 | Dec 2013 → Aug 2015 | dyspepsia | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qizhiweitong granule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02460601 ↗ |
| Known as | Qi-Zhi-Wei-Tong granules | “Qi-Zhi-Wei-Tong granules offer significant symptomatic improvement in PDS with no more adverse effects than placebo.” PMID 29941708 ↗ Jul 2018 |
| Route | Oral | “2.5g/time,tid,oral administration,6 weeks” NCT02460601 ↗ |